RNL BIO CO LTD

The world's first commercially cloned dogs were sent home last month. The company recommends pet owners to be prepared for dogs' sudden death by saving live cells while they are alive.

RNL Bio launches the world's first human stem cell based cosmetics, Dr. JUCRE.

RNL's stem cell clinic is specialized in cell therapies for degenerative diseases and anti-aging treatments using intravenous injections of stem cells and accepting patients from North America and Europe.

RNL Bio offers an exceptional promotion for dog cloning at hugely discounted cost.

- Five clones from ‘Booger’ were born by world’s first commercial order. - The project completed in only 70 days, boasting the efficacy of the technology. - RNL starts to offer cloning service, world-wide.

Two surrogate mother dogs diagnosed pregnant with three fetuses with estimated delivery due of July 25

RNL warns BioArts for patent infringement as its first patent right exercise

RNL Bio has signed a licensing agreement with a Japanese biotech company for RNL's stem cell technology to establish stem cell banks and to sell the stem cell therapeutics in Japan

The world's first drug-sniffing canine clones were qualified for the evaluation of the good qualities in qualification test.

Starting this April, a clinical trial will test the potential of treating patients suffering from Romberg’s disease at The Asan Medical Center in Seoul, Korea.